Comparison of transarterial chemoembolization and hepatic resection for large solitary hepatocellular carcinoma: A propensity score analysis

Journal of Vascular and Interventional Radiology

Volumn 26, Issue 5, 2015, Pages 651-659

  Lee, Yun Bin ^a,c   Lee, Dong Hyeon ^a   Cho, Yuri ^a   Yu, Su Jong ^a   Lee, Jeong Hoon ^a   Yoon, Jung Hwan ^a   Lee, Hyo Suk ^a   Kim, Hyo Cheol ^b   Yi, Nam Joon ^b   Lee, Kwang Woong ^b   Suh, Kyung Suk ^b   Chung, Jin Wook ^b   Kim, Yoon Jun ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; DOXORUBICIN; HEPATITIS B SURFACE ANTIGEN; MITOMYCIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASCITES; BILE LEAKAGE; CANCER GROWTH; CANCER SIZE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHILD PUGH SCORE; COMPARATIVE STUDY; DRUG FEVER; FEMALE; FOLLOW UP; HUMAN; JAUNDICE; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PLEURA EFFUSION; PORTAL HYPERTENSION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TUMOR NECROSIS; VERY ELDERLY; WOUND HEALING IMPAIRMENT; CARCINOMA, HEPATOCELLULAR; COMPLICATION; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HEPATITIS B SURFACE ANTIGENS; HUMANS; HYPERTENSION, PORTAL; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS;

EID: 84928825819     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2015.02.004     Document Type: Article

References (33)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. European Association for the Study of the Liver European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
3. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
4. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
5. A. Forner, M.E. Reig, C.R. de Lope, and J. Bruix Current strategy for staging and treatment: the BCLC update and future prospects Semin Liver Dis 30 2010 61 74
6. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
7. M. Sala, J.M. Llovet, and R. Vilana Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma Hepatology 40 2004 1352 1360
8. K.N. Khan, H. Yatsuhashi, and K. Yamasaki Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection J Hepatol 32 2000 269 278
9. D.S. Lu, N.C. Yu, and S.S. Raman Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver Radiology 234 2005 954 960
10. T. Ishizawa, K. Hasegawa, and T. Aoki Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma Gastroenterology 134 2008 1908 1916
11. J.M. Llovet, and J. Bruix Novel advancements in the management of hepatocellular carcinoma in 2008 J Hepatol 48 Suppl 1 2008 S20 S37
12. N. Portolani, A. Coniglio, and S. Ghidoni Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications Ann Surg 243 2006 229 235
13. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
14. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
15. C. Couinaud Contribution of anatomical research to liver surgery Fr Med 19 1956 5 12
16. G.E. Chung, J.H. Lee, and H.Y. Kim Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival Radiology 258 2011 627 634
17. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
18. R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
19. J.M. Llovet, J. Fuster, and J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1999 1434 1440
20. H.G. Welch, L.M. Schwartz, and S. Woloshin Are increasing 5-year survival rates evidence of success against cancer? JAMA 283 2000 2975 2978
21. X. Calvet, J. Bruix, and P. Gines Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients Hepatology 12 1990 753 760
22. J. Bruix, A. Castells, and J. Bosch Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure Gastroenterology 111 1996 1018 1022
23. S. Miyayama, M. Yamashiro, and M. Okuda Chemoembolization for the treatment of large hepatocellular carcinoma J Vasc Interv Radiol 21 2010 1226 1234
24. Y. Baba, S. Hayashi, and K. Ueno Comparison of survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma Oncol Lett 1 2010 905 911
25. Y. Shiratori, S. Shiina, and M. Imamura Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan Hepatology 22 1995 1027 1033
26. P. Tandon, and G. Garcia-Tsao Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies Liver Int 29 2009 502 510
27. S.S. Lee, H.S. Shin, and H.J. Kim Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience Korean J Hepatol 18 2012 48 55
28. J. Luo, Z.W. Peng, and R.P. Guo Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis Radiology 259 2011 286 295
29. J. Belghiti, Y. Panis, O. Farges, J.P. Benhamou, and F. Fekete Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis Ann Surg 214 1991 114 117
30. T.J. Green, P.J. Rochon, and S. Chang Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization J Vasc Interv Radiol 24 2013 1613 1622
31. M. Burrel, M. Reig, and A. Forner Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads. Implications for clinical practice and trial design J Hepatol 56 2012 1330 1335
32. S.C. Schiffman, C.E. Woodall, and D.A. Kooby Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis J Surg Oncol 101 2010 105 110
33. G. Torzilli, N. Olivari, and E. Moroni Contrast-enhanced intraoperative ultrasonography in surgery for hepatocellular carcinoma in cirrhosis Liver Transpl 10 2004 S34 S38